| Joseph W Kosnik, MD | |
|
4005 Orchard Dr, Midland, MI 48670-0001 | |
| (989) 839-3100 | |
| (989) 839-1393 |
| Full Name | Joseph W Kosnik |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 4005 Orchard Dr, Midland, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376586883 | NPI | - | NPPES |
| 4182331 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4301047073 (Michigan) | Primary |
| Entity Name | Emergency Professionals Of Indiana Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013951219 PECOS PAC ID: 4183604150 Enrollment ID: O20040721000612 |
News Archive
Hypertrophic cardiomyopathy (HCM) is consistent with survival to normal life expectancy, including particularly advanced age into the tenth decade of life, with demise ultimately largely unrelated to this disease, according to a study being presented Nov. 13 at the American Heart Association (AHA) scientific sessions in Orlando, Fla.
Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration for an indication expansion for Eisai's antiepileptic drug Fycompa (perampanel) to cover partial-onset seizures in pediatric patients with epilepsy 4 years of age and older.
Last year at the DMC Children's Hospital of Michigan, nearly 500 children were treated and admitted for burn injuries. As a result of the spectrum of quality care provided to burn patients from the pre-hospital phase through the rehabilitation process and having met rigorous standards for specific criteria set by the American Burn Association and the Committee on Trauma of the American Colleges of Surgeons, the DMC Children's Hospital of Michigan burn center is now the state's only verified pediatric burn center exclusively dedicated to the needs of children.
The Wall Street Journal offers a collection of stories that looks at changes in health care that could yield big responses: "Health-care innovations come in many shapes and sizes ... [including] the kind that can help reach the goal that continues to elude our policy makers: getting good care to the greatest number of people in the most cost-effective way."
New research at the Hebrew University of Jerusalem sheds light on pluripotency-the ability of embryonic stem cells to renew themselves indefinitely and to differentiate into all types of mature cells.
› Verified 6 days ago
| Entity Name | App Of Indiana Ed, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740822212 PECOS PAC ID: 2961835400 Enrollment ID: O20191213001639 |
News Archive
Hypertrophic cardiomyopathy (HCM) is consistent with survival to normal life expectancy, including particularly advanced age into the tenth decade of life, with demise ultimately largely unrelated to this disease, according to a study being presented Nov. 13 at the American Heart Association (AHA) scientific sessions in Orlando, Fla.
Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration for an indication expansion for Eisai's antiepileptic drug Fycompa (perampanel) to cover partial-onset seizures in pediatric patients with epilepsy 4 years of age and older.
Last year at the DMC Children's Hospital of Michigan, nearly 500 children were treated and admitted for burn injuries. As a result of the spectrum of quality care provided to burn patients from the pre-hospital phase through the rehabilitation process and having met rigorous standards for specific criteria set by the American Burn Association and the Committee on Trauma of the American Colleges of Surgeons, the DMC Children's Hospital of Michigan burn center is now the state's only verified pediatric burn center exclusively dedicated to the needs of children.
The Wall Street Journal offers a collection of stories that looks at changes in health care that could yield big responses: "Health-care innovations come in many shapes and sizes ... [including] the kind that can help reach the goal that continues to elude our policy makers: getting good care to the greatest number of people in the most cost-effective way."
New research at the Hebrew University of Jerusalem sheds light on pluripotency-the ability of embryonic stem cells to renew themselves indefinitely and to differentiate into all types of mature cells.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph W Kosnik, MD Po Box 1903, Midland, MI 48641-1903 Ph: (989) 839-1941 | Joseph W Kosnik, MD 4005 Orchard Dr, Midland, MI 48670-0001 Ph: (989) 839-3100 |
News Archive
Hypertrophic cardiomyopathy (HCM) is consistent with survival to normal life expectancy, including particularly advanced age into the tenth decade of life, with demise ultimately largely unrelated to this disease, according to a study being presented Nov. 13 at the American Heart Association (AHA) scientific sessions in Orlando, Fla.
Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration for an indication expansion for Eisai's antiepileptic drug Fycompa (perampanel) to cover partial-onset seizures in pediatric patients with epilepsy 4 years of age and older.
Last year at the DMC Children's Hospital of Michigan, nearly 500 children were treated and admitted for burn injuries. As a result of the spectrum of quality care provided to burn patients from the pre-hospital phase through the rehabilitation process and having met rigorous standards for specific criteria set by the American Burn Association and the Committee on Trauma of the American Colleges of Surgeons, the DMC Children's Hospital of Michigan burn center is now the state's only verified pediatric burn center exclusively dedicated to the needs of children.
The Wall Street Journal offers a collection of stories that looks at changes in health care that could yield big responses: "Health-care innovations come in many shapes and sizes ... [including] the kind that can help reach the goal that continues to elude our policy makers: getting good care to the greatest number of people in the most cost-effective way."
New research at the Hebrew University of Jerusalem sheds light on pluripotency-the ability of embryonic stem cells to renew themselves indefinitely and to differentiate into all types of mature cells.
› Verified 6 days ago
Carleton D Winegar, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3100 Fax: 989-839-1393 | |
Dr. Belinda Hoover Brewster, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2677 E Blackhurst Rd, Midland, MI 48642 Phone: 989-837-6632 Fax: 989-837-6632 | |
Dr. Zachary J Sawaya, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4000 Wellness Dr, Midland, MI 48670 Phone: 989-839-3000 Fax: 989-839-1393 | |
Erich Christian Kickland, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3100 | |
Jesse G Walker, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3100 Fax: 989-839-1393 | |
Jeffrey S Newman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4005 Orchard Dr, Midland, MI 48670 Phone: 989-839-3100 Fax: 989-839-1393 | |
Dr. David Eric Newcomb Ii, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Emergency Department Mid-michigan Regional Med Ctr, 4005 Orchard Drive, Midland, MI 48670 Phone: 989-839-3230 |